ROUNDUP: AbbVie Raises FY26 Adj. EPS Outlook; Boost Dividend 5.2%

What happened

AbbVie raised its full-year 2026 adjusted earnings guidance to $13.95 to $13.99 per share and declared a 5.2 percent higher quarterly cash dividend of $1.82 per share, payable February 16, 2027 to shareholders of record on January 15, 2027.

Confirmed

Global impact / market context

A higher profit forecast signals management expects stronger results, which can support the stock price. The bigger dividend means each share pays more cash, which may attract income-focused investors and modestly raise AbbVie's cash returned to shareholders.

Analyst inference

AbbVie shares traded at $292.00 before the market opened, up $1.11 or 0.38 percent. That small gain suggests investors reacted mildly, while the dividend increase and raised guidance may support positioning in the stock.

Analyst inference

What to watch

1. The dividend is $1.82 per share, payable February 16, 2027, to shareholders of record as of January 15, 2027, so investors must own shares by the record date. Confirmed
2. Watch whether AbbVie's board keeps raising the dividend in later quarters, since a steady series of increases would signal confidence in cash flow. Proposed
3. Watch actual 2026 adjusted earnings against the $13.95 to $13.99 range, because missing the raised forecast could weaken investor confidence in management's outlook. Analyst inference

Evidence

• Original source link unavailable